NF-κB/MAPK-IN-2
NF-κB/MAPK-IN-2 (compound 14) is a potent NF-κB and MAPK Inhibitor. NF-κB/MAPK-IN-2 decreases the protein expression of p-p65, p-IκB, p-p38, p-JNK, and p-ERK. NF-κB/MAPK-IN-2 reduces the LPS-induced release of TNF-α and IL-6. NF-κB/MAPK-IN-2 inhibits nuclear translocation of p65 and c-Fos. NF-κB/MAPK-IN-2 has the potential for the research of sepsis[1].
Product Specifications
UNSPSC
12352005
Target
NF-κB; p38 MAPK
Related Pathways
MAPK/ERK Pathway; NF-κB
Field of Research
Cancer
Smiles
C[C@]1(C2=C(C[C@]3([C@@]1([H])CC[C@@]4([C@]3([H])CC=C5[C@]4(CC[C@@]6([C@@]5([H])CC(C)(CC6)C)C(OCC7=CC=CC=C7)=O)C)C)C)C(C(OCC)=O)=NO2)COC(CCC(N8CCOCC8)=O)=O
Molecular Formula
C49H66N2O9
Molecular Weight
827.06
References & Citations
[1]Xie W, et al. Design and Synthesis of Hederagenin Derivatives for the Treatment of Sepsis by Targeting TAK1 and Regulating the TAK1-NF-κB/MAPK Signaling. J Med Chem. 2025 Jan 16.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940204-500 1x 500 µL
Complement C4d (C4D204), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400679-500 1x 500 µL
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880040-100 1x 100 µL
CD35 / CR1 (E11), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681810-100 1x 100 µL
Spectrin Alpha 1 (Erythrocyte Marker) (SPTA1/1810), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details